scispace - formally typeset
R

Richard M. Epand

Researcher at McMaster University

Publications -  521
Citations -  26937

Richard M. Epand is an academic researcher from McMaster University. The author has contributed to research in topics: Membrane & Peptide. The author has an hindex of 80, co-authored 515 publications receiving 25125 citations. Previous affiliations of Richard M. Epand include Brigham Young University & University of Edinburgh.

Papers
More filters
Journal ArticleDOI

Phosphatidylcholine structure determines cholesterol solubility and lipid polymorphism

TL;DR: It is demonstrated that phosphatidylcholine with (16:1)9 acyl chains undergoes polymorphic rearrangements in mixtures with 0.6-0.8 mol fraction cholesterol, and the formation of highly curved bilayer structures, such as those required for membrane fusion, can occur in mixture of cholesterol with certain phosphatids that do not form non-lamellar structures in the absence of cholesterol.
Journal ArticleDOI

Effect of phase transitions on the interaction of peptides and proteins with phospholipids.

TL;DR: The molecular basis for preferential interaction with gel state lipid is suggested to be the ability of proteins to self-associate, probably at defect sites, below the phase transition temperature and thereby increase protein-protein interactions while maintaining protein-lipid and lipid-lipids interactions.
Book ChapterDOI

Liposomes as models for antimicrobial peptides.

TL;DR: Lobosomes are useful tools to identify the mechanism of action of antimicrobial peptides, and they provide a simple system to complement cell studies for optimization of the potency and specificity of these agents.
Journal ArticleDOI

Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.

TL;DR: A number of analogues of this peptide hormone with deletions in the carboxyl terminus of this putative amphipathic helix have hypocalcemic activity in vivo in rats, comparable to the native hormone, except for des-Leu19-salmon calcitonin, which is about twice as active as the unmodified hormone.
Journal ArticleDOI

Conformational studies on analogs of recombinant parathyroid hormone and their interactions with phospholipids.

TL;DR: It is suggested that this enhanced activity is a consequence of the altered lipid interaction of +6RPTH, combined with increased conformational flexibility, particularly in the carboxyl-terminal region of the molecule.